肾结核患者血清和尿液人软骨糖蛋白-39表达水平及其诊断和预后评估的价值

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (528 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the expression level of human cartilage glycoprotein-39 in serum and urine of patients with renal tuberculosis and its diagnostic and prognostic value. Methods A total of 80 patients with renal tuberculosis admitted to the Department of Urology, the First Affiliated Hospital of Hebei North University (“our hospital” for short) from May 2019 to May 2020 were selected as the observation group, and 50 healthy people in our hospital were selected as the control group. Enzyme-linked immunosorbent assay was used to detect the concentration of human cartilage glycoprotein-39 in the serum and urine of the two groups, and the expression level of human cartilage glycoprotein-39 in serum and urine of renal tuberculosis patients and its diagnostic and prognostic value were explored. Results The levels of human cartilage glycoprotein-39 in urine and serum specimens of the observation group were significantly higher than those of the control group, and the differences were statistically significant (P ＜ 0.05). The expression level of human cartilage glycoprotein-39 in renal tuberculosis lesion tissue was significantly higher than that in normal tissues around the week, and the difference was statistically significant (P ＜ 0.05). The area under the ROC curve of human cartilage glycoprotein-39 was larger than that of PCR, and the difference was highly statistically significant (P ＜ 0.01). Conclusion The level of human cartilage glycoprotein-39 in the urine and serum of patients with renal tuberculosis is significantly higher than that of normal people. The preliminary diagnosis of renal tuberculosis can be made by understanding the level of human cartilage glycoprotein-39 in the patient’s body.

Key words： Renal tuberculosis Human cartilage glycoprotein-39 Diagnosis Prognosis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	AN Haixia LI Xiujun YANG Jiaxin CHEN Huai’an

Cite this article:

AN Haixia LI Xiujun YANG Jiaxin CHEN Huai’an. Expression of human cartilage glycoprotein-39 in serum and urine of patients with renal tuberculosis and its diagnostic and prognostic value[J]. 中国医药导报, 2021, 18(18): 80-83.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I18/80

[1] 陈怀安，刘硕，王哲，等.YKL-40在肾结核患者中的表达及临床意义[J].临床泌尿外科杂志，2019，34（12）：953-956.
[2] 罗逊，刘曼婷，李世瑶，等.血清YKL-40、FABP4水平与腹膜透析患者容量超负荷的关系[J].山东医药，2018，58（41）：30-33.
[3] 代海涛，程帆，刘昌茂，等.肾细胞癌中人软骨糖蛋白39在外周血及组织的表达[J].中华实验外科杂志，2020，37（1）：166-168.
[4] 于志暄，王云枝.YKL-40和MPV在2型糖尿病早期肾病的临床价值[J].中华临床医师杂志：电子版，2017，11（7）：1110-1113.
[5] 周忻，林杰，陈力平，等.肾损伤早期诊断标志物在高强度军事训练过程中的变化[J].中国急救复苏与灾害医学杂志，2019，14（11）：1056-1059.
[6] 陈怀安，刘硕，李秀君，等.甲壳质酶蛋白40对肾结核的诊断效能及关系研究[J].中国现代医学杂志，2019，29（14）：110-113.
[7] 陈怀安，安海霞，刘硕，等.甲壳质酶蛋白40联合诊断肾结核的临床意义[J].中华实验外科杂志，2019，36（7）：1174.
[8] 王玲，贲素琴.YKL-40与呼吸系统疾病相关的研究进展[J].国际呼吸杂志，2020，40（5）：390-394.
[9] 侯永强，王新征.血清YKL-40蛋白水平与肝硬化患者肝功能、肝纤维化的相关性及作用机制[J].中西医结合肝病杂志，2019，29（5）：427-429.
[10] 张辉，周文平，刘刚琼，等.YKL-40 RNA干扰对载脂蛋白E基因敲除小鼠动脉粥样硬化的影响[J].实用医学杂志，2019，35（14）：2200-2203.
[11] 张永芳，廖建华，蒲元林，等.反复肺炎患儿体内免疫应答、炎症反应与YKL-40含量的相关性分析[J].海南医学院学报，2018，24（11）：1093-1096，1100.
[12] 马卫银，彭韶，张婷.反复肺炎患儿血清YKL-40与体液免疫功能的变化及意义[J].中国当代儿科杂志，2017， 19（4）：425-429.
[13] 王焕，崔凯，徐可，等.2型糖尿病肾病患者血清YKL-40与动脉粥样硬化的关系[J].中国中西医结合肾病杂志，2015，16（1）：57-58.
[14] 朱慧静，杨明明，程霖，等.不同程度糖尿病慢性肾脏疾病患者血清YKL-40水平变化及其临床意义的观察[J].中国糖尿病杂志，2015（8）：720-722.
[15] 代海涛，程帆，刘昌茂，等.肾细胞癌中人软骨糖蛋白39在外周血及组织的表达[J].中华实验外科杂志，2020， 37（1）：166-168.
[16] 江柳，许玉峰，唐光健.肾结核与非结核梗阻性肾积水形态差异的影像研究[J].中华放射学杂志，2018，52（12）： 923-926.
[17] 张红玲，李长凤，沈元丽.血清CA72-4、CA125和YKL-40水平与卵巢上皮癌患者病理特征的关系[J].癌症进展，2020，18（2）：160-163，167.
[18] Ashkan P，Shaghayegh S，Omid ZS，et al. Local Expression of Mucosal YKL-40; Correlation of YKL-40 with Clinical Manifestations and Immunopathogenesis of Moderate/Severe Persistent Allergic Rhinitis Patients [J]. Immunol Invest，2020，49（1/2）：46-57.
[19] Daniel A，David JI，Ignacio IG，et al. Elevated YKL-40 and low sAPPβ：YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD [J]. J Neurol，2019，90（2）：180-186.
[20] Naglaa A，Aly EA，Abeer EH，et al. YKL-40，fetuin-A plasma levels，and carotid intima-media thickness：do they have relations with subclinical atherosclerosis associated with psoriasis and the disease severity? [J]. J Egypt Soc Parasitol，2019，16（2）：133-141.
[21] Jiang LL，Wang YL，Peng QL，et al. Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody [J]. Clin Rheumatol，2019，38（6）：1655-1663.
[22] Olfat GS，Hebatullah SH. Circulating Bone-related Markers and YKL-40 Versus HER2 and TOPO2a in Bone Metastatic and Nonmetastatic Breast Cancer：Diagnostic Implications [J]. Clin Breast Cancer，2018，18（3）：E321-E328.
[23] Hampel H，Lamari F，Floris R，et al. Alzheimer’s disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates：A beta（1-42），total-tau，phosphorylated-tau，NFL，neurogranin，and YKL-40 [J]. Alzheimers Dement，2018，14（4）：492-501.
[24] Tian X，Chong KZ，Aili W，et al. YKL-40 is a novel biomarker for predicting hypertension incidence among prehypertensive subjects：A population-based nested case-control study in China [J]. Clin Chim Acta，2017， 472：146-150.
[25] Sini D，Dhoom M. Effect of scaling and root planing on gingival crevicular fluid level of YKL-40 acute phase protein in chronic periodontitis patients with or without type 2 diabetes mellitus：A clinico-biochemical study [J]. J Indian Soc Perio，2018，22（1）：40-44.